Evidence map›Paper›PMID 30201601›Full record

ArticleJMIR mHealth and uHealth2018

Smartphone-Based Contingency Management Intervention to Improve Pre-Exposure Prophylaxis Adherence: Pilot Trial.

John T Mitchell, Sara LeGrand, Lisa B Hightow-Weidman, Mehri S McKellar, Angela Dm Kashuba, Mackenzie Cottrell, Tony McLaurin, Goutam Satapathy, F Joseph McClernon

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in JMIR mHealth and uHealth, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02895893 (PrEP SMART PHASE I TRIAL), which is not on this map. Cited by 33 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 7 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02895893 phase1completednot on this map

PrEP SMART PHASE I TRIAL

TypeinterventionalSponsorDuke UniversityRan2016 to 2017Enrolled12ConditionsAt Risk for HIVArmsPrEP Smart
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 7 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Prize-Based Incentives for Smoking Cessation Among People With HIV: A Sequential Multiple Assignment Randomized Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

John T Mitchell *Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, United States.ORCID http://orcid.org/0000-0002-9586-3823
Sara LeGrandCenter for Health Policy and Inequalities Research at Duke University, Duke Global Health Institute, Durham, NC, United States.ORCID http://orcid.org/0000-0002-2590-516X
Lisa B Hightow-WeidmanInstitute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.ORCID http://orcid.org/0000-0002-2421-923X
Mehri S McKellarDivision of Infectious Diseases, Duke University Medical Center, Durham, NC, United States.ORCID http://orcid.org/0000-0003-2942-5398
Angela Dm KashubaDivision of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.ORCID http://orcid.org/0000-0002-9171-8493
Mackenzie CottrellDivision of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.ORCID http://orcid.org/0000-0002-0291-5111
Tony McLaurinDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, United States.ORCID http://orcid.org/0000-0001-8318-3612
Goutam SatapathyIntelligent Automation Incorporated, Rockville, NC, United States.ORCID http://orcid.org/0000-0002-4992-6192
F Joseph McClernonDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, United States.ORCID http://orcid.org/0000-0002-2846-980X
Duke University · USUniversity of North Carolina at Chapel Hill · USDuke Medical Center · USIntelligent Automation (United States) · US

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI064518
6 · The paper itself

Abstract

backgroundPre-exposure prophylaxis (PrEP) provides a strong preventative benefit to individuals at risk for HIV. While PrEP adherence is highly correlated with its efficacy, adherence rates are variable both across and within persons.

objectiveThe objective of this study was to develop and pilot-test a smartphone-based intervention, known as mSMART, that targets PrEP adherence. mSMART provides contingency management in the form of monetary incentives for daily PrEP adherence based on a real-time adherence assessment using a camera-based medication event-monitoring tool as well as medication reminders, PrEP education, individualized behavioral strategies to address PrEP adherence barriers, and medication adherence feedback.

methodsThis was a 4-week open-label, phase I trial in a community sample of young men who have sex with men already on PrEP (N=10).

resultsAlthough adherence composite scores corresponding to PrEP biomarkers indicated that 90% (9/10) of the sample already had an acceptable baseline adherence in the protective range, by the end of the 4-week period, the scores improved for 30% (3/10) of the sample-adherence did not worsen for any participants. Participants reported mean PrEP adherence rates of 91% via daily entries in mSMART. At the end of the 4-week period, participants indicated acceptable ratings of satisfaction, usability, and willingness to recommend mSMART to others. There were no technical difficulties associated with smartphone compatibility, user misunderstandings about mSMART features that interfered with daily use, or study attrition.

conclusionsThis study is the first to apply contingency management to PrEP adherence. Findings indicated that mSMART is feasible and acceptable. Such an adherence intervention administered via a user-friendly smartphone app can allow for widespread dissemination. Future efficacy trials are needed.

trial registrationClinicalTrials.gov NCT02895893; https://clinicaltrials.gov/ct2/show/NCT02895893 (Accessed by Webcite at http://www.webcitation.org/72JskjDJq).

Indexed as

HIVmobile healthpreexposure prophylaxis

Identifiers

PMID30201601
PMCPMC6231728
OpenAlexW2808018342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.